1 / 18

Use of Safety Monitoring Flow Sheets

Use of Safety Monitoring Flow Sheets. Background. Flow sheets can serve as useful tools Not required but recommended Tailor for ease of use AND usefulness at your site When tailoring, consider staff roles and responsibilities AND other documentation requirements at your site. Flow Sheets.

elvis-young
Download Presentation

Use of Safety Monitoring Flow Sheets

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Use of Safety Monitoring Flow Sheets

  2. Background • Flow sheets can serve as useful tools • Not required but recommended • Tailor for ease of use AND usefulness at your site • When tailoring, consider staff roles and responsibilities AND other documentation requirements at your site

  3. Flow Sheets • Height and weight • Vital signs • Hematology • Liver function: ALT and AST • Renal function: phosphate and creatinine

  4. Common Elements • Title • Brief instructions/guidance • Date and visit code • Values being monitored • Staff Initials • Shading indicates “not applicable”

  5. General Instructions for Use • Initiate use during screening • File for “easy access” in participant study notebook • Update at or after each visit • Continually review as part of ongoing safety monitoring • Initial and date to document reviews

  6. Height • Why are there two rows to record height on each date?

  7. Height • Because the protocol requires repeat measurement if a decrease of 3.8 cm or more is identified • Record NA if a second measurement is not required and therefore is not done • Severity grading is not required

  8. Weight • Why is percentage difference from Screening Part 2 needed?

  9. Weight • Because the severity of unintentional weight loss must be graded in terms of percent decrease 01 JAN 2010 07 JAN 2010 15 APR 2010 6.0 (M3) 50 50 45 50 – 45 = 5 5 10% 5 ÷ 50 = 0.10 = 10%

  10. Vital Signs • Fever (oral temp), hypertension, and hypotension must be graded • For hypertension, grading requires repeat blood pressure measurement at the same visit

  11. Hematology

  12. Hematology • Hemoglobin, platelets, white blood cells, neutrophils, and lymphocytes must be graded • Hemoglobin is graded based on absolute values and difference from Screening Part 1 • Neutrophils and lymphocytes are graded based on absolute counts • Although not recorded on flow sheet, abnormal differential counts should also be monitored for clinical significance

  13. ALT and AST • All results should be graded • Grading is based on the site upper limit of normal (record at top of flow sheet for ease of reference)

  14. Phosphate • All results should be graded • Grading is based on the site lower limit of normal (record at top of flow sheet for ease of reference)

  15. Creatinine

  16. Creatinine • Absolute levels must be graded (based on site upper limit of normal) • Increases from baseline must be calculated to determine whether product hold is required • Creatinine clearance rate must be calculated to determine whether product hold is required

  17. Creatinine: Relative Increase From Baseline • Participant is a 23 year old, 57 kg woman, oral study product 1.5 mg/dL 0.8 mg/dL 01 JAN 2010 15 APR 2010 6.0 (M3) 0.8 mg/dL 0 0.9 mg/dL 0 1.1 0.9 ÷ 0.8 = 1.1 99 mL/min 87 mL/min

  18. What are your … • Questions? • Comments? • Concerns?

More Related